Trial Watch:, OncoImmunology, vol.57, issue.6, p.28694, 2014. ,
DOI : 10.4161/onci.25396
Oncolytic virotherapy, Nature Biotechnology, vol.311, issue.7, pp.658-70, 2012. ,
DOI : 10.1038/nbt.2287
Talimogene Laherparepvec Improves Durable Response Rate in Patients With Advanced Melanoma, Journal of Clinical Oncology, vol.33, issue.25, 2015. ,
DOI : 10.1200/JCO.2014.58.3377
The future of immune checkpoint therapy, Science, vol.348, issue.6230, pp.56-61, 2015. ,
DOI : 10.1126/science.aaa8172
Antitumor Virotherapy by Attenuated Measles Virus (MV), Biology, vol.2, issue.2, pp.587-602, 2013. ,
DOI : 10.3390/biology2020587
Oncolytic Measles Virus Expressing the Sodium Iodide Symporter to Treat Drug-Resistant Ovarian Cancer, Cancer Research, vol.75, issue.1, pp.22-30, 2015. ,
DOI : 10.1158/0008-5472.CAN-14-2533
Remission of Disseminated Cancer After Systemic Oncolytic Virotherapy, Mayo Clinic Proceedings, vol.89, issue.7, pp.926-959, 2014. ,
DOI : 10.1016/j.mayocp.2014.04.003
Oncolysis of vascular malignant human melanoma tumors by Coxsackievirus A21, International Journal of Oncology, vol.26, pp.1471-1477, 2005. ,
DOI : 10.3892/ijo.26.6.1471
Reolysin is a novel reovirus-based agent that induces endoplasmic reticular stress-mediated apoptosis in pancreatic cancer, Cell Death and Disease, vol.9, issue.7, p.728, 2013. ,
DOI : 10.1038/onc.2011.478
Randomized dose-finding clinical trial of oncolytic immunotherapeutic vaccinia JX-594 in liver cancer, Nature Medicine, vol.53, issue.3, pp.329-365, 2013. ,
DOI : 10.1038/nm.3089
Reciprocal cellular cross-talk within the tumor microenvironment promotes oncolytic virus activity, Nature Medicine, vol.43, issue.5, pp.530-536, 2015. ,
DOI : 10.1038/nm.3848
Diverse roles of STING-dependent signaling on the development of cancer, Oncogene, vol.34, issue.41, 2015. ,
DOI : 10.1016/j.cell.2011.04.022